Partners

Strong partnerships complement our core team’s discovery and pre-GMP production expertise. PROGENITER has established an extensive network of partnerships between public and private entities.

This initiative was undertaken thanks in part to funding from the Canada Biomedical Research Fund and the Biosciences Research Infrastructure Fund.

PROGENITER, part of the UBC-led Canada’s Immuno-Engineering and Biomanufacturing Hub, aims to discover, design, engineer, and deliver antibody-based treatments against infectious diseases.